Free webinar: Intravenous iron in heart failure
Thursday 27th February 2020

If you missed our webinar, you can watch it now

Our webinar is aimed at all grades of health care professionals treating the cardiorenal patient particularly those in cardiology, nephrology, care of the elderly, general medicine, general practitioners, clinical pharmacists and allied disciplines.

Make sure your colleagues don’t miss out!

Why is it important?

It’s well recognised that patients with chronic and acute heart failure suffer from iron deficiency, which greatly affects their quality of life reducing their exercise capacity and feeling of well-being. It is also associated with more severe symptoms and a poorer prognosis.

It’s estimated that almost half of all heart failure patients are anaemic so it’s vitally important that we accurately diagnose iron deficiency in our heart failure patients and optimally treat it. Too often, its management is suboptimal.

This may be because oral iron products in heart failure have not been particularly effective. But newer, intravenous iron products do show good efficacy and are recommended in guidelines but its regular administration can be challenging for patients and health care services.

To help update you with current thinking on iron deficiency in heart failure, including its prevalence, its clinical impact, the current guidelines, treatment options and practical tips on service implementation, we are urging you to join our experts and the discussion in our webinar ‘Intravenous iron in heart failure’.

We are able to provide this webinar free of charge to health care professionals, thanks to funding from Pharmacosmos UK Limited.

The Cardiorenal Forum organised the programme and selected the speakers.

  Webinar lead: Professor Paul Kalra, Consultant Cardiologist, Portsmouth Hospitals NHS Trust
Introduction Professor Paul Kalra, Consultant Cardiologist, Portsmouth Hospitals NHS Trust
Chronic heart failure – current treatments and why we need new therapeutic targets Professor Mark Petrie, Professor/Honorary Consultant, Institute of Cardiovascular and Medical Sciences, University of Glasgow
Questions and answers
Iron deficiency in heart failure – epidemiology, association with outcomes and current data on intervention Dr Paul WX Foley, Consultant Cardiologist, Great Western Hospital Foundation Trust, Swindon
What guidelines say and rationale for hard end-point studies: including an update on IRONMAN Professor Paul Kalra Portsmouth Hospitals NHS Trust; University of Portsmouth
Questions and answers
Practical considerations for intravenous iron management Professor Philip Kalra, Consultant Nephrologist, Salford Royal NHS Foundation Trust; Professor of Renal Medicine, University of Manchester
Administration of intravenous iron – a nursing perspective Ms Serena Howe, Specialist Research Nurse, Portsmouth Hospitals NHS Trust
Questions and answers

Meet our speakers

Paul WX Foley (Consultant Cardiologist, The Great Western Hospital, Swindon) has an interest in cardiovascular research, cardiac failure, device therapy and cardiovascular magnetic resonance.

Serena Howe (Specialist Research Nurse, Portsmouth Hospitals NHS Trust) qualified over 15 years ago with a background in elderly medicine and acute stroke care. Since 2011, she has specialised in research nursing, focusing on cardiology studies. Part of a high-performing research team she leads, coordinates, and contributes to a diverse portfolio of research studies, including interventional and observational protocols. She has a keen interest in heart failure and is the national lead nurse for IRONMAN and the Principal Investigator for SYMPACT.

Paul Kalra (Consultant Cardiologist, Portsmouth Hospitals NHS Trust, and and Honorary Professor of Cardiology) has research interests that include the pathophysiology of heart failure, including the impact of anaemia. He is one of the founders of the Cardiorenal Forum and past Chair of the British Society for Heart Failure.

Meet our speakers

Philip Kalra (Professor of Renal Medicine, University of Manchester and Consultant Nephrologist at the Salford Royal NHS Foundation Trust) is lead of the renal research team at Salford Royal Hospital, which has a major focus on cardiovascular disease in kidney patients. He was co-originator and lead nephrologist for the ASTRAL trial and was the chair of the NIHR CRN National Renal speciality group between 2010–2018. He is the current Academic Vice President of the Renal Association and Chair of the UK Kidney Research Consortium. He has played a significant role in amalgamating cardiorenal education and research within the UK. He is one of the founders of the Cardiorenal Forum.

Mark Petrie (Professor/Honorary Consultant, Institute of Cardiovascular and Medical Sciences, University of Glasgow) worked as a heart failure and interventional cardiologist for many years before transferring to the University of Glasgow in 2016. He was Director of the Scottish National Advanced Heart Failure Service 2010–2014 and has served on the National Advisory Committee for Heart Disease 2004–2018. He established and chaired the Scottish Heart Failure Hub 2014–2017. Mark has published around 130 original manuscripts and has leadership roles in many trials including STICH, REVIVED, REDUCE-LAP, PARADISE-MI, Dapa-HF and IRONMAN. He was an author of the 2011 European Society of Cardiology NSTEMI Guidelines and a reviewer of the 2016 ESC Heart Failure Guidelines.


Would you like us to send you regular updates about the activities of the Cardiorenal Forum, including meetings?

You can also find out more here about our Privacy policy and Terms and conditions.

Cardiorenal Froum 2019


of delegates said the 2019 meeting
was clinically excellent or good


of delegates found the 2019 programme
to be good to excellent


of delegates said the 2019 meeting organisation
was good to excellent